Lv1
10 积分 2024-05-05 加入
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
15天前
已完结
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
17天前
已完结
Side effects of prostate cancer therapies and potential management
17天前
已完结
TGF-β in developmental and fibrogenic EMTs
20天前
已完结
Efficacy and Safety of 225Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
20天前
已完结
The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
24天前
已关闭
Favorable Response of 225Ac-PSMA in the Treatment of Castration-Resistant Prostate Cancer With High Bone Metastasis Burden
24天前
已完结
225Ac‐PSMA‐617‐targeted alpha therapy for the treatment of metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis
1个月前
已完结
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review
1个月前
已完结
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations
1个月前
已完结
皖公网安备34019202002308
